AbCellera Biologics Statistics
Total Valuation
ABCL has a market cap or net worth of $1.49 billion. The enterprise value is $952.02 million.
Important Dates
The next confirmed earnings date is Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ABCL has 298.48 million shares outstanding. The number of shares has increased by 1.78% in one year.
| Current Share Class | 298.48M |
| Shares Outstanding | 298.48M |
| Shares Change (YoY) | +1.78% |
| Shares Change (QoQ) | +0.74% |
| Owned by Insiders (%) | 22.97% |
| Owned by Institutions (%) | 35.42% |
| Float | 202.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 63.81 |
| Forward PS | 61.25 |
| PB Ratio | 1.46 |
| P/TBV Ratio | 1.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 41.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.15, with a Debt / Equity ratio of 0.07.
| Current Ratio | 10.15 |
| Quick Ratio | 8.86 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -15.59% and return on invested capital (ROIC) is -15.83%.
| Return on Equity (ROE) | -15.59% |
| Return on Assets (ROA) | -12.94% |
| Return on Invested Capital (ROIC) | -15.83% |
| Return on Capital Employed (ROCE) | -22.90% |
| Revenue Per Employee | $38,782 |
| Profits Per Employee | -$281,658 |
| Employee Count | 596 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -42.76M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +65.78% in the last 52 weeks. The beta is 0.62, so ABCL's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | +65.78% |
| 50-Day Moving Average | 3.14 |
| 200-Day Moving Average | 2.83 |
| Relative Strength Index (RSI) | 69.34 |
| Average Volume (20 Days) | 7,342,880 |
Short Selling Information
The latest short interest is 30.42 million, so 10.19% of the outstanding shares have been sold short.
| Short Interest | 30.42M |
| Short Previous Month | 26.52M |
| Short % of Shares Out | 10.19% |
| Short % of Float | 15.03% |
| Short Ratio (days to cover) | 4.07 |
Income Statement
In the last 12 months, ABCL had revenue of $23.11 million and -$167.87 million in losses. Loss per share was -$0.57.
| Revenue | 23.11M |
| Gross Profit | -147.35M |
| Operating Income | -290.53M |
| Pretax Income | -178.81M |
| Net Income | -167.87M |
| EBITDA | -231.20M |
| EBIT | -290.53M |
| Loss Per Share | -$0.57 |
Full Income StatementBalance Sheet
The company has $605.27 million in cash and $67.85 million in debt, giving a net cash position of $537.42 million or $1.80 per share.
| Cash & Cash Equivalents | 605.27M |
| Total Debt | 67.85M |
| Net Cash | 537.42M |
| Net Cash Per Share | $1.80 |
| Equity (Book Value) | 1.02B |
| Book Value Per Share | 3.43 |
| Working Capital | 689.58M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$78.40 million and capital expenditures -$64.89 million, giving a free cash flow of -$143.29 million.
| Operating Cash Flow | -78.40M |
| Capital Expenditures | -64.89M |
| Free Cash Flow | -143.29M |
| FCF Per Share | -$0.48 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,256.95% |
| Pretax Margin | -911.27% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ABCL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.78% |
| Shareholder Yield | -1.78% |
| Earnings Yield | -11.27% |
| FCF Yield | -9.62% |
Analyst Forecast
The average price target for ABCL is $8.75, which is 75.35% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.75 |
| Price Target Difference | 75.35% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 48.44% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ABCL has an Altman Z-Score of 1.67 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.67 |
| Piotroski F-Score | 2 |
